Efficacy and Safety of Romidepsin CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma

NCT01796002 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

421

Enrollment

OTHER

Sponsor class

Conditions

Peripheral T-cell Lymphoma

Interventions

DRUG: Romidepsin + CHOP
DRUG: CHOP

Sponsor

The Lymphoma Academic Research Organisation